Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Flexus Biosciences logo — Bristol-Myers Squibb acquired Flexus for $800M upfront & $45...

Flexus Biosciences

Bristol-Myers Squibb acquired Flexus for $800M upfront & $450M in potential earnouts in 2015.

Founded 2013 1 employees Venture round Total: $66.20M Biopharma, Biotechnology +1

General Information

Company Name Flexus Biosciences
Founded Year 2013
Employees 1
Industries Biopharma, Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Flexus Biosciences. To contact Flexus Biosciences, visit flexusbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Flexus Biosciences

Flexus Biosciences, a biopharmaceutical startup founded in 2013, drew significant attention in 2015 when it was acquired by Bristol-Myers Squibb for a substantial amount of $800M upfront and $450M in potential earnouts. The company focuses on developing and commercializing novel anti-cancer therapeutics using unexploited insights in immunology. The innovative approach of Flexus attracted the interest of notable investors, with Kleiner Perkins contributing to the $15.20M venture round investment in March 2015. The acquisition by a pharmaceutical giant like Bristol-Myers Squibb demonstrates the promising potential and value that Flexus Biosciences offered within the biopharma, biotechnology, and healthcare industries.

Taxonomy: Biopharmaceutical, Cancer Therapeutics, Immunology, Oncology Research, Drug Development, Discovery Research, Biotech, Pharmaceutical, Innovation, Biomedical, Cancer Treatment, Therapeutic Development

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $15.20M 1
Kleiner Perkins
Kleiner Perkins
20 Mar 2015
Series B $38.00M 3
Kleiner Perkins The Column Group Celgene
Kleiner Perkins, The Column Group +1
17 Dec 2014
Series A $13.00M 1
Kleiner Perkins
Kleiner Perkins
01 Oct 2013

Flexus Biosciences Alternatives & Competitors

Flexus Biosciences vs
Anchiano Therapeutics
Anchiano Therapeutics United States

Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat...

Post-IPO Equity
1 employees
Biotechnology, Health Care
Flexus Biosciences vs
Xanthus Pharmaceuticals
Xanthus Pharmaceuticals

Innovative treatments for cancer and autoimmune disorders through pioneering small-molecule therapeu...

Series B
Biopharma, Biotechnology
Flexus Biosciences vs
Genus Oncology LLC
Genus Oncology LLC

Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomorrow

Series A
3 employees
Biotechnology, Health Care

FAQ About Flexus Biosciences

Bristol-Myers Squibb acquired Flexus for $800M upfront & $450M in potential earnouts in 2015.
Flexus Biosciences was founded in 2013.
Flexus Biosciences operates in Biopharma, Biotechnology and Health Care. Its work centres on Biopharmaceutical, Cancer Therapeutics, Immunology and Oncology Research.
Flexus Biosciences has approximately 1 employees.
Flexus Biosciences has completed 3 funding rounds, raising a total of $66.20M. The latest funding stage is Venture round.
Top alternatives and competitors to Flexus Biosciences include Anchiano Therapeutics, Xanthus Pharmaceuticals, Genus Oncology LLC, Coherus BioSciences, Sunesis Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Flexus Biosciences and Anchiano Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Flexus Biosciences, https://bouncewatch.com/company/flexus-biosciences, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes